Abstract:Objective To investigate the role of calcium/calmodulin-dependent protein kinase Ⅱ (CaMK Ⅱ) in the primary somatosensory area (S1 area) and hippocampi in reduction of remifentanil-induced hyperalgesia by lidocaine in rats.Methods One hundred fifty-six male Sprague-Dawley rats,aged 8-10 weeks,weighing 240-260 g,were randomly allocated into 4 groups using a radom number table:control group (group C,n=6),remifentanil group (group R,n=50),lidocaine group (group L,n=50),and remifentanil+lidocaine group (group RL,n =50).Remifentanil was given as a bolus of 6 mg/kg followed by an 2 h infusion of 2.4 μg · kg-1 · min-1 in group R.Lidocaine was given as a bolus of 6 mg/kg followed by an infusion of 200 μg · kg-1 · min-1 for 2 h in group L.In group RL,drug administration was similar to those previously described in R and L groups.The mechanical paw withdrawal threshold (MWT) and thermal paw withdrawal latency (TWL) were measured before administration and at 0.5,2,5 and 24 h after the end of administration.The rats were then sacrificed immediately after administration and at 0.5,2,5 and 24 h after the end of administration in R,L and RL groups,or at the corresponding time point in group C.The S1 area and hippocampi were isolated for determination of phosphorylated CaMK Ⅱ (p-CaMK Ⅱ) expression by Western blot.Results Compared with the value before administration,the MWT was significantly decreased at 0.5 and 2 h after the end of administration (P＜0.05),and no significant change was found in TWL at each time point after the end of administration in R,L and RL groups (P＞0.05).Compared with group C,p-CaMK Ⅱ expression in the S1 area and hippocampi was significantly up-regulated immediately after administration and at 0.5 and 2 h after the end of administration in group R (P＜0.05).Compared with group R,p-CaMK Ⅱ expression in the S1 area and hippocampi was significantly down-regulated immediately after administration and at 0.5 and 2 h after the end of administration in group RL,and p-CaMK Ⅱ expression in the S1 area was significantly down-regulated immediately after administration,and at 0.5 and 2 h after the end of administration,and p-CaMK Ⅱ expression in the hippocampi was down-regulated immediately after administration,and at 0.5,2 and 24 h after the end of administration in group L,and MWT was increased at 0.5 and 2 h after the end of administration in groups L and RL (P＜0.05).There was no significant difference in TWL at each time point among the three groups (P＞0.05).Conclusion The mechanism by which lidocaine mitigates remifentanil-induced hyperalgesia is associated with inhibited activity of CaMKII in the S1 area and hippocampi of rats.

Dezocine Attenuates the Remifentanil-Induced Postoperative Hyperalgesia by Inhibition of Phosphorylation of CaMKⅡα.

Ketamine Reduces Remifentanil-Induced Postoperative Hyperalgesia Mediated by CaMKII-NMDAR in the Primary Somatosensory Cerebral Cortex Region in Mice.

Dezocine For Preventing Postoperative Pain: A Meta-Analysis Of Randomized Controlled Trials

Intrathecal Injection of KN93 Attenuates Paradoxical Remifentanil-Induced Postoperative Hyperalgesia by Inhibiting Spinal CaMKII Phosphorylation in Rats

Dexmedetomidine Prevents Remifentanil-Induced Postoperative Hyperalgesia and Decreases Spinal Tyrosine Phosphorylation of N-methyl-d-aspartate Receptor 2B Subunit.

Prevention of Remifentanil Induced Postoperative Hyperalgesia by Dexmedetomidine Via Regulating the Trafficking and Function of Spinal NMDA Receptors As Well As PKC and CaMKII Level in Vivo and in Vitro

Δ-opioid receptor inhibition prevents remifentanil-induced post-operative hyperalgesia via regulating GluR1 trafficking and AMPA receptor function

Phosphorylated CaMKII Levels Increase in Rat Central Nervous System after Large-Dose Intravenous Remifentanil

Ciprofol alleviates remifentanil-induced hyperalgesia by regulating α2GABAARs, NR2B, and P-CaMKIIα levels in the spinal cord and hippocampus

Effects of CaMK Ⅱ Inhibitor KN93 on Remifentanil-Induced Hyperalgesia

Inhibition of DOR prevents remifentanil induced postoperative hyperalgesia through regulating the trafficking and function of spinal NMDA receptors in vivo and in vitro

Role of Mitochondrial Ca2+ Uniporter in Remifentanil‐induced Postoperative Allodynia

P2Y1 Purinergic Receptor Inhibition Attenuated Remifentanil-Induced Postoperative Hyperalgesia Via Decreasing NMDA Receptor Phosphorylation in Dorsal Root Ganglion.

Tyrosine Phosphorylation of the N-Methyl-D-Aspartate Receptor 2B Subunit in Spinal Cord Contributes to Remifentanil-Induced Postoperative Hyperalgesia: the Preventive Effect of Ketamine

Intrathecal Administration of Roscovitine Prevents Remifentanil-Induced Postoperative Hyperalgesia and Decreases the Phosphorylation of N-methyl-D-aspartate Receptor and Metabotropic Glutamate Receptor 5 in Spinal Cord.

Influence of dexmedetomidine on expressions of PKCγ, CaMKⅡαand pCaMKⅡαin spinal cord in rats with hyperalgesia

N-acetyl-cysteine Attenuates Remifentanil-Induced Postoperative Hyperalgesia Via Inhibiting Matrix Metalloproteinase-9 in Dorsal Root Ganglia

Role of CaMK Ⅱ in primary somatosensory area and hippocampi in reduction of remifentanil-induced hyperalgesia by lidocaine in rats

Antinociception and Prevention of Hyperalgesia by Intrathecal Administration of Ro 25-6981, a Highly Selective Antagonist of the 2B Subunit of N-methyl-d-aspartate Receptor

PKCε Contributes to Remifentanil-Induced Hyperalgesia Via Downregulating Mu-Opioid Receptor in Rat Dorsal Root Ganglion Neurons

Role of CaMK II in primary somatosensory area and hippocampi in reduction of remifentanil-induced hyperalgesia by lidocaine in rats